Journal Home
Search for

Volume 21, Issue 7, Pages 493-501 (November 2009)


View previous. 7 of 20 View next.

Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children

Senthilkumar Sadhasivam, MD, MPH (Associate Professor)Corresponding Author Informationemail address, Anne Boat, MD, Mohamed Mahmoud, MD

Received 21 March 2008; received in revised form 1 December 2008; accepted 1 December 2008. published online 23 October 2009.

Abstract 

Study Objective

To evaluate the effect of dexmedetomidine as an adjunct to patient-controlled analgesia (PCA) with morphine.

Design

Retrospective comparison.

Setting

University-affiliated children's hospital.

Measurements

The medical charts of 131 children with idiopathic scoliosis (IS) and NMS who had major spine surgery were reviewed. Out of 131, postoperatively 94 children received PCA with morphine alone (PCA group) and the remaining 37 children received PCA morphine and dexmedetomidine infusion at 0.4 mcg/kg/hour for 24 hours (PCA + Dex group). Preoperative, intraoperative, and postoperative morphine use data were collected.

Main Results

Intraoperative use of morphine was similar in children with IS and NMS. However, patients with IS used more morphine than patients with NMS on the first, second and third postoperative days in both groups. In children with IS, use of morphine on the second postoperative day was significantly higher in the PCA + Dex group (73 mg [50.5, 110.5]) than the PCA alone group (54 mg [36, 69], P = 0.03). The overall frequency of all perioperative complications was more in the PCA alone group (40% vs. 32%) than the PCA + Dex group.

Conclusion

Postoperative 24-hour dexmedetomidine infusion as an adjunct to PCA with opioids might have a morphine-sparing effect as evidenced by the increase in morphine use on postoperative day 2 after the dexmedetomidine infusion was stopped.

Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, MLC 2001, Cincinnati, OH 45229, USA

Corresponding Author InformationCorresponding author. Tel.: +1 513 636 4408; fax: +1 513 636 7337.

PII: S0952-8180(09)00254-2

doi:10.1016/j.jclinane.2008.12.017


View previous. 7 of 20 View next.